Caredx Inc’s recent filing unveils that its Secretary and General Counsel Novack Jeffrey Adam unloaded Company’s shares for reported $81829.0 on Feb 04 ’25. In the deal valued at $23.30 per share,3,512 shares were sold. As a result of this transaction, Novack Jeffrey Adam now holds 104,677 shares worth roughly $2.19 million.
Then, Jeffrey Adam Novack bought 3,512 shares, generating $81,900 in total proceeds.
Before that, Novack Jeffrey Adam sold 1,917 shares. Caredx Inc shares valued at $49,842 were divested by the Secretary and General Counsel at a price of $26.00 per share. As a result of the transaction, Novack Jeffrey Adam now holds 110,237 shares, worth roughly $2.3 million.
Wells Fargo upgraded its Caredx Inc [CDNA] rating to an Equal weight from a an Underweight in a research note published on January 15, 2025; the price target was decreased to $24 from $28. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who began to cover the stock in late August with a ‘”an Underweight”‘ rating. BTIG Research also remained covering CDNA and has increased its forecast on August 19, 2024 with a “Buy” recommendation from previously “Neutral” rating. Raymond James revised its rating on May 13, 2024. It rated CDNA as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of CDNA
On Tuesday, Caredx Inc [NASDAQ:CDNA] saw its stock fall -2.25% to $20.89. Over the last five days, the stock has lost -14.70%. Caredx Inc shares have fallen nearly -2.43% since the year began. Nevertheless, the stocks have risen 152.60% over the past one year. While a 52-week high of $34.84 was reached on 01/14/25, a 52-week low of $7.42 was recorded on 02/25/25. SMA at 50 days reached $22.69, while 200 days put it at $22.50.
Levels Of Support And Resistance For CDNA Stock
The 24-hour chart illustrates a support level at 20.00, which if violated will result in even more drops to 19.10. On the upside, there is a resistance level at 21.54. A further resistance level may holdings at 22.18. The Relative Strength Index (RSI) on the 14-day chart is 38.96, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.83, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.34%. Stochastics %K at 14.05% indicates the stock is a buying.
